| Matthew Thibodeaux, OD | |
|
13322 Highway 90 Ste L, Boutte, LA 70039-3010 | |
| (985) 785-8484 | |
| (985) 785-8483 |
| Full Name | Matthew Thibodeaux |
|---|---|
| Gender | Male |
| Speciality | Optometrist |
| Location | 13322 Highway 90 Ste L, Boutte, Louisiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194249086 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 1859-793AT (Louisiana) | Primary |
| Provider Name | Eyecare Providers, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1477628154 PECOS PAC ID: 2567359318 Enrollment ID: O20040304000481 |
News Archive
Nearly half of American women having a baby in the last decade received a prescription for a powerful opioid painkiller as part of their birth experience, a new study shows.
Studies presented at the 2007 meeting of the American Association for Cancer Research show how researchers are using the new, as well as the natural, to help design and test new drugs to treat cancer.
Using tiny chemotherapy-soaked beads to choke off and kill cancerous liver tumors is becoming more successful, according to research being presented at the 21st annual International Symposium on Endovascular Therapy (ISET).
A new study compares the pathogenicity and infectiousness of one such variant, the VOC 202012/01 (B.1.1.7 lineage) from the United Kingdom, with the globally dominant D614G mutation-carrying strains.
By taking two standard laboratory techniques - capillary electrophoresis and antibody-based protein detection - and shrinking them to the nanoscale, researchers at the Stanford University School of Medicine have created a new method for detecting miniscule changes in the levels of proteins associated with cancer.
› Verified 8 days ago
| Provider Name | Artis Beatty A Professional Optometry Corporation |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1912416355 PECOS PAC ID: 3678831187 Enrollment ID: O20171211000692 |
News Archive
Nearly half of American women having a baby in the last decade received a prescription for a powerful opioid painkiller as part of their birth experience, a new study shows.
Studies presented at the 2007 meeting of the American Association for Cancer Research show how researchers are using the new, as well as the natural, to help design and test new drugs to treat cancer.
Using tiny chemotherapy-soaked beads to choke off and kill cancerous liver tumors is becoming more successful, according to research being presented at the 21st annual International Symposium on Endovascular Therapy (ISET).
A new study compares the pathogenicity and infectiousness of one such variant, the VOC 202012/01 (B.1.1.7 lineage) from the United Kingdom, with the globally dominant D614G mutation-carrying strains.
By taking two standard laboratory techniques - capillary electrophoresis and antibody-based protein detection - and shrinking them to the nanoscale, researchers at the Stanford University School of Medicine have created a new method for detecting miniscule changes in the levels of proteins associated with cancer.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew Thibodeaux, OD 1950 Old Gallows Rd Ste 520, Vienna, VA 22182-3970 Ph: (703) 847-8899 | Matthew Thibodeaux, OD 13322 Highway 90 Ste L, Boutte, LA 70039-3010 Ph: (985) 785-8484 |
News Archive
Nearly half of American women having a baby in the last decade received a prescription for a powerful opioid painkiller as part of their birth experience, a new study shows.
Studies presented at the 2007 meeting of the American Association for Cancer Research show how researchers are using the new, as well as the natural, to help design and test new drugs to treat cancer.
Using tiny chemotherapy-soaked beads to choke off and kill cancerous liver tumors is becoming more successful, according to research being presented at the 21st annual International Symposium on Endovascular Therapy (ISET).
A new study compares the pathogenicity and infectiousness of one such variant, the VOC 202012/01 (B.1.1.7 lineage) from the United Kingdom, with the globally dominant D614G mutation-carrying strains.
By taking two standard laboratory techniques - capillary electrophoresis and antibody-based protein detection - and shrinking them to the nanoscale, researchers at the Stanford University School of Medicine have created a new method for detecting miniscule changes in the levels of proteins associated with cancer.
› Verified 8 days ago
Myeyedr. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 13322 Highway 90 Ste L, Boutte, LA 70039 Phone: 985-807-1373 | |
St. Charles Vision Outlet Optometrist Medicare: Not Enrolled in Medicare Practice Location: 13322 Highway 90, Suite L, Boutte, LA 70039 Phone: 985-785-8484 Fax: 985-785-8483 | |
St. Charles Vision Optometrist Medicare: Not Enrolled in Medicare Practice Location: 13322 Highway 90, Suite L, Boutte, LA 70039 Phone: 985-785-8484 Fax: 985-785-8483 | |
Dr. Janie Tran, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 13001 Highway 90, Boutte, LA 70039 Phone: 985-785-0855 |